Protein, Sarcopenic Obesity, and COPD

Launched by UNIVERSITY OF ABERDEEN · Dec 10, 2024

Keywords

ClinConnect Summary

This clinical trial, titled "Protein, Sarcopenic Obesity, and COPD," is designed to explore how the amount and type of protein in our diets may influence two important health issues: sarcopenic obesity (a condition where you have too much fat and not enough muscle) and chronic obstructive pulmonary disease (COPD), which affects breathing. The study will focus on older women aged 55 and above who have been diagnosed with COPD. Researchers want to understand how dietary protein intake and inflammation relate to both sarcopenic obesity and lung function, which could help improve treatment strategies for participants.

If you are a woman over 55 with COPD, you might be eligible to participate in this study. However, individuals with certain conditions, like dementia or cancer, or those who cannot read or write in English, won’t be able to take part. Those who join the study can expect to provide information about their diet and health, and they will help researchers uncover important insights into how protein intake might support better lung health and muscle strength in older adults with COPD. This research could lead to more effective ways to manage these conditions and improve quality of life.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Women.
• • Clinically diagnosed with COPD.
• • Aged 55 years or older.
• Exclusion Criteria:
• • Male.
• • Women who are 54 years or younger.
• • Those who have dementia.
• • Unable to read or write in English.
• • Unable to attend the Human Intervention Studies Unit.
• • Those within one year life expectancy.
• • Those who have cancer.